Cargando…
A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay
Drug hypersensitivity reactions can lead to different clinical pictures depending on the underlying immunological mechanism. Diagnosis tests are already available to assess the most frequent drugs hypersensitivity reactions, which are mediated by specific IgE or T cells. However, it remains challeng...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796899/ https://www.ncbi.nlm.nih.gov/pubmed/29434608 http://dx.doi.org/10.3389/fimmu.2018.00110 |
_version_ | 1783297567765823488 |
---|---|
author | Viel, Sébastien Pescarmona, Rémi Belot, Alexandre Nosbaum, Audrey Lombard, Christine Walzer, Thierry Bérard, Frédéric |
author_facet | Viel, Sébastien Pescarmona, Rémi Belot, Alexandre Nosbaum, Audrey Lombard, Christine Walzer, Thierry Bérard, Frédéric |
author_sort | Viel, Sébastien |
collection | PubMed |
description | Drug hypersensitivity reactions can lead to different clinical pictures depending on the underlying immunological mechanism. Diagnosis tests are already available to assess the most frequent drugs hypersensitivity reactions, which are mediated by specific IgE or T cells. However, it remains challenging to diagnose type 2 hypersensitivity reactions (T2HR), which can lead to severe cytopenia and liver failure. Here, we describe a case of T2HR to rasburicase, an uricolytic agent used to prevent tumor lysis syndrome. In this patient, sensitization was associated with the production of specific IgG able to bind to leukocytes. We found that patient NK cells were specifically activated in the presence of rasburicase and autologous serum, which led to exocytosis of lytic granules. This antibody-dependent cell cytotoxicity mechanism may lead to cytopenia observed in the patient. Moreover, this NK cell activation assay could be used to improve the diagnosis of a T2HR to rasburicase and, by extent, to other drugs. These data also suggest that NK cells could play an important role in the pathophysiological mechanism of T2HR. |
format | Online Article Text |
id | pubmed-5796899 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57968992018-02-12 A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay Viel, Sébastien Pescarmona, Rémi Belot, Alexandre Nosbaum, Audrey Lombard, Christine Walzer, Thierry Bérard, Frédéric Front Immunol Immunology Drug hypersensitivity reactions can lead to different clinical pictures depending on the underlying immunological mechanism. Diagnosis tests are already available to assess the most frequent drugs hypersensitivity reactions, which are mediated by specific IgE or T cells. However, it remains challenging to diagnose type 2 hypersensitivity reactions (T2HR), which can lead to severe cytopenia and liver failure. Here, we describe a case of T2HR to rasburicase, an uricolytic agent used to prevent tumor lysis syndrome. In this patient, sensitization was associated with the production of specific IgG able to bind to leukocytes. We found that patient NK cells were specifically activated in the presence of rasburicase and autologous serum, which led to exocytosis of lytic granules. This antibody-dependent cell cytotoxicity mechanism may lead to cytopenia observed in the patient. Moreover, this NK cell activation assay could be used to improve the diagnosis of a T2HR to rasburicase and, by extent, to other drugs. These data also suggest that NK cells could play an important role in the pathophysiological mechanism of T2HR. Frontiers Media S.A. 2018-01-29 /pmc/articles/PMC5796899/ /pubmed/29434608 http://dx.doi.org/10.3389/fimmu.2018.00110 Text en Copyright © 2018 Viel, Pescarmona, Belot, Nosbaum, Lombard, Walzer and Bérard. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Viel, Sébastien Pescarmona, Rémi Belot, Alexandre Nosbaum, Audrey Lombard, Christine Walzer, Thierry Bérard, Frédéric A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay |
title | A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay |
title_full | A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay |
title_fullStr | A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay |
title_full_unstemmed | A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay |
title_short | A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay |
title_sort | case of type 2 hypersensitivity to rasburicase diagnosed with a natural killer cell activation assay |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796899/ https://www.ncbi.nlm.nih.gov/pubmed/29434608 http://dx.doi.org/10.3389/fimmu.2018.00110 |
work_keys_str_mv | AT vielsebastien acaseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay AT pescarmonaremi acaseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay AT belotalexandre acaseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay AT nosbaumaudrey acaseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay AT lombardchristine acaseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay AT walzerthierry acaseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay AT berardfrederic acaseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay AT vielsebastien caseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay AT pescarmonaremi caseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay AT belotalexandre caseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay AT nosbaumaudrey caseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay AT lombardchristine caseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay AT walzerthierry caseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay AT berardfrederic caseoftype2hypersensitivitytorasburicasediagnosedwithanaturalkillercellactivationassay |